Ephedrine Sulfate (Ephedrine Sulfate) Patent Expiration, LOE Window & CMS Spending

Ephedrine Sulfate (Ephedrine Sulfate) by Ph Health: FDA Orange Book LOE 2040-01-22, 15 AB generics, $5.2M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPh Health
FDA Application & PathwayN213994 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2040-01-22
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors15
2024 CMS Total Public Spend$5.2M
2024 Medicare Part D Spend$0
2024 Medicaid Spend$5.2M
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel